Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $12.18 and traded as high as $12.47. Bavarian Nordic shares last traded at $12.47, with a volume of 1,038 shares changing hands.
Bavarian Nordic Stock Performance
The stock has a market capitalization of $2.96 billion, a price-to-earnings ratio of 14.33 and a beta of 1.27. The company’s 50 day moving average is $12.18 and its 200 day moving average is $10.14.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last released its earnings results on Friday, August 22nd. The company reported $0.23 EPS for the quarter. The firm had revenue of $251.14 million during the quarter. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%. On average, equities research analysts anticipate that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.
Bavarian Nordic Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Recommended Stories
- Five stocks we like better than Bavarian Nordic
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What Are Treasury Bonds?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
